Analyst Reco. AstraZeneca PLC

Equities

Real-time Estimate Cboe Europe Other stock markets 10:46:08 2024-04-23 am EDT			5-day change	1st Jan Change
11,238 ^GBX	-0.11%		+3.31%	+6.02%

03:38pm	AstraZeneca's Voydeya Approved as Add-on Therapy in Europe for Blood Disorder	MT
10:50am	ASTRAZENECA : JP Morgan reaffirms its Buy rating	ZD

ASTRAZENECA : JP Morgan reaffirms its Buy rating	04:50am	ZD
ASTRAZENECA : Receives a Buy rating from JP Morgan	Apr. 17	ZD
ANALYST RECOMMENDATIONS : Las Vegas Sands, Regeneron, Kinder Morgan, Rivian, Royal Caribbean...	Apr. 17
ASTRAZENECA : Deutsche Bank returns to 'Hold	Apr. 16	CF
Deutsche Bank Upgrades AstraZeneca to Hold from Sell, Lifts PT	Apr. 16	MT
ASTRAZENECA : Deutsche Bank drops its Sell rating	Apr. 16	ZD
ANALYST RECOMMENDATIONS : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca	Apr. 16
RBC raises Admiral; Barclays cuts Phoenix Group	Apr. 16	AN
ASTRAZENECA : Barclays reiterates its Buy rating	Apr. 15	ZD
Fitch Affirms AstraZeneca Rating on Stable Position in Pharmaceutical Sector	Apr. 12	MT
Shareholder Says AstraZeneca CEO 'Massively Underpaid'	Apr. 10	MT
ASTRAZENECA : Gets a Buy rating from Barclays	Apr. 08	ZD
ASTRAZENECA : Gets a Sell rating from UBS	Apr. 05	ZD
ASTRAZENECA : JP Morgan reiterates its Buy rating	Apr. 05	ZD
ASTRAZENECA : JP Morgan keeps its Buy rating	Apr. 04	ZD
ASTRAZENECA : AstraZeneca should not be overlooked for long	Apr. 03
Bernstein Starts AstraZeneca Coverage at Outperform	Apr. 02	MT
Bernstein starts AstraZeneca at 'outperform'	Apr. 02	AN
Advisers Urge Shareholders to Vote Against AstraZeneca CEO's Pay Plan	Apr. 01	MT
ASTRAZENECA : Deutsche Bank reiterates its Sell rating	Mar. 28	ZD

No results for this search

ASTRAZENECA : AstraZeneca should not be overlooked for long

April 03, 2024 at 10:26 am EDT